W. D. Wells-Gatnik Et Al. , "Emerging experimental drugs in clinical trials for migraine: observations and key talking points," Expert Opinion on Investigational Drugs , vol.32, no.8, pp.761-771, 2023
Wells-Gatnik, W. D. Et Al. 2023. Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert Opinion on Investigational Drugs , vol.32, no.8 , 761-771.
Wells-Gatnik, W. D., Wences Chirino, T. Y., Onan, F. N., ONAN, D., & Martelletti, P., (2023). Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert Opinion on Investigational Drugs , vol.32, no.8, 761-771.
Wells-Gatnik, William Et Al. "Emerging experimental drugs in clinical trials for migraine: observations and key talking points," Expert Opinion on Investigational Drugs , vol.32, no.8, 761-771, 2023
Wells-Gatnik, William D. Et Al. "Emerging experimental drugs in clinical trials for migraine: observations and key talking points." Expert Opinion on Investigational Drugs , vol.32, no.8, pp.761-771, 2023
Wells-Gatnik, W. D. Et Al. (2023) . "Emerging experimental drugs in clinical trials for migraine: observations and key talking points." Expert Opinion on Investigational Drugs , vol.32, no.8, pp.761-771.
@article{article, author={William David Wells-Gatnik Et Al. }, title={Emerging experimental drugs in clinical trials for migraine: observations and key talking points}, journal={Expert Opinion on Investigational Drugs}, year=2023, pages={761-771} }